Discover
Longevity.Technology UNLOCKED
Longevity.Technology UNLOCKED
Author: Longevity.Technology
Subscribed: 3Played: 68Subscribe
Share
© Longevity.Technology
Description
Longevity.Technology UNLOCKED brings together science, business, and human potential to explore the frontier of longer, healthier living.
🎙 Mondays: In-depth conversations with scientists, founders, investors, operators, and elite performers shaping the longevity ecosystem.
đź§ Fridays: A sharp weekly round-up of the biggest stories, trends, and insights from across the longevity space.
If you’re curious about the future of health, performance, and lifespan, this is where it gets UNLOCKED.
🎙 Mondays: In-depth conversations with scientists, founders, investors, operators, and elite performers shaping the longevity ecosystem.
đź§ Fridays: A sharp weekly round-up of the biggest stories, trends, and insights from across the longevity space.
If you’re curious about the future of health, performance, and lifespan, this is where it gets UNLOCKED.
82Â Episodes
Reverse
Guest:Dr. Sara MahdaviInternational Scholar & Collaborator at Harvard University, Adjunct Professor & Clinician Scientist at the University of TorontoLinkedIn: https://www.linkedin.com/in/dr-sara-mahdavi-437129369/Website: https://www.drsaramahdavi.com/Dr David CoxNeuroscientist, Health & Medical Journalist, and Author of The Age CodeLinkedIn: https://www.linkedin.com/in/dr-david-cox-6b219666/_______________What if the diet that helps someone live longer could be wrong for you?Phil Newman speaks with David Cox, author of The Age Code, and Dr Sara Mahdavi, physician and precision nutrition researcher, about how genetics can shape our response to food.They explore nutrigenetics, caffeine metabolism and chrononutrition, including why meal timing may affect people differently. They also examine sex differences in fasting, the role of genetic variants such as MTHFR, and how biological data could inform more personalized health decisions.The conversation looks at the promise and limitations of AI in interpreting complex health data, and why scientific evidence and clinical expertise remain essential.In this episode, you'll learn:- How genes can influence food preferences and metabolism- Why caffeine affects people differently- How circadian rhythms may shape meal timing- Why fasting can affect women and men differently- Where AI could take personalized nutrition nextThe future of nutrition may be less about universal rules and more about understanding individual biology.Subscribe for weekly episodes on longevity science, preventative medicine and healthier, longer live_______________Host:Â Phil Newman: https://qrco.de/bgXpNY
Guest:Christin Glorioso, MD. Ph.D.Creator of the Younger Biological Aging Contest, Founder & CEO of NeuroAge TherapeuticsLinkedIn: https://www.linkedin.com/in/christin-glorioso-md-phd-39627719/Website: https://www.neuroagetx.com/authors/christin-gloriosoRyan SmithCo-Founder and Director of Research & Development at TruDiagnosticLinkedIn: https://www.linkedin.com/in/ryan-smith-lexington-ky/Website: https://www.trudiagnostic.com/_______________What if measuring biological age could show which interventions actually improve health?Phil Newman sits down with Dr. Christin Glorioso, physician, neuroscientist and founder of NeuroAge and Longevity Global, and Ryan Smith of True Diagnostic to explore the Younger biological aging contest and the future of aging biomarkers.They explain how its six-month challenge combines DNA methylation, proteomics, RNA and glycan clocks with brain imaging and physical-function tests. The resulting data could help compare biomarkers, personalize interventions and strengthen evidence for clinical trials.They also discuss brain health, GLP-1 research, surrogate endpoints and how AI could accelerate biomarker validation.In this episode, you'll learn:- What Younger measures- How multi-omics can refine biological age testing- Which lifestyle factors show promising signals- How brain data can guide personalized recommendations- What biomarkers need before regulators can rely on themThis episode connects emerging aging science with practical routes toward personalized, preventative healthcare.Subscribe for weekly episodes on longevity science, preventative medicine and healthier, longer lives._______________Host:Â Phil Newman: https://qrco.de/bgXpNY
Guest:Dr. Steven N. Austad, Ph.D.Distinguished Professor of Biology at University of Alabama at BirminghamLinkedIn: https://www.linkedin.com/in/steven-austad-b31b5090/Website: https://www.uab.edu/cas/biology/people/faculty/steven-n-austadAlan Richardson, Ph.D.Professor of Biochemistry & Physiology at University of Oklahoma Health Sciences CenterLinkedIn: https://www.linkedin.com/in/arlan-richardson-357977b3/Website: https://medicine.ouhsc.edu/directory/details/arlan-richardson-phd-1_______________What if some of the best clues to human longevity are already hidden across the animal kingdom?Phil Newman sits down with aging researchers Steven Austad and Arlan Richardson to explore what decades of animal research can teach us about extending human healthspan.Together they explain why mice remain valuable but imperfect models, and how bowhead whales, naked mole rats, bats and 500-year-old clams reveal different biological routes to longevity. They also discuss genetically diverse rats, dietary restriction, fasting and the challenge of translating laboratory discoveries into humans.In this episode, you'll learn:- Why mice alone cannot model human aging- What exceptionally long-lived species reveal- Why genetic diversity matters- How fasting differs from chronic calorie restriction- Why GLP-1s, proteomics and AI could accelerate longevity researchIf you want to understand where longevity research goes next, this episode connects evolutionary biology with emerging human therapeutics.Subscribe for weekly episodes that explore longevity science, preventative med_______________Host:Â Phil Newman: https://qrco.de/bgXpNY
Guest:Jamie Justice, Ph.D.Executive Director, XPRIZE Healthspan and Vice President of the Health Domain at XPRIZE FoundationLinkedIn: https://www.linkedin.com/in/jamie-justice-ph-d-6b933146/Website: https://www.xprize.org/Steven R. Cummings, MDExecutive Director at S.F. Coordinating Center (SFCC) in the CPMC Research InstituteLinkedIn: https://www.linkedin.com/in/steve-cummings-71668514a/Website: https://www.xprize.org/people/steve-cummings_______________What if the breakthrough longevity needs isn’t another intervention, but a better way to prove what works?Phil Newman sits down with XPRIZE Healthspan director Jamie Justice and judging chair Professor Steven Cummings to explore the $101 million competition.Together they explain why muscle, cognitive and immune function form its evidence framework, and how one-year trials could help model longer-term healthspan gains. From repurposed drugs to gene therapies, finalists must demonstrate measurable effects under common standards.They also discuss FDA pathways, scalability, safety and prevention versus reversal.In this episode, you'll learn:- How finalists are judged- Why function matters beyond biomarkers- How trials model 10–20 years of decline- Why scalability matters- Why safety could determine successIf you want to understand how longevity interventions could become credible medicine, this episode connects rigorous trials with real-world healthspan.Subscribe for weekly episodes that explore longevity science, preventative medicine, and the systems shaping how we live longer and better._______________Host: Phil Newman: https://qrco.de/bgXpNY
Sponsor: Sooo.meSooo.me™ is a longevity-focused nutraceutical brand offering science-backed supplements designed to support healthy aging, energy, focus, cellular health, and overall wellbeing. Its range combines high-purity ingredients, medicinal mushroom extracts, and targeted formulations with an emphasis on quality, transparency, and sustainable packaging.See what it can do for you — click below to try it today and use code LONGEVITYTECHNO for 10% off.Link: https://sooo.me/?ref=LTUNLOCKED----------Guests:John BeardIrene Diamond Professor and Director International Longevity Center USA, Columbia UniversityLinkedIn: https://www.linkedin.com/in/john-beard-987b801b/Website: https://www.publichealth.columbia.edu/profile/john-beard-mbbs----------What if the way we measure health is holding back the science of aging?Phil Newman sits down with Dr. John Beard, Irene Diamond Professor and Director of the International Longevity Centre USA at Columbia University, to explore intrinsic capacity – measuring health through what people can actually be and do rather than the diseases they have.Together they unpack the five domains of intrinsic capacity and why functional measures could give researchers a more continuous picture of aging. From simple chair-rise and hearing tests to clinical trial endpoints, biomarkers and wearables, Beard explains both the potential and the gaps that remain.They also discuss why “70 is the new 60,” the difference between prevention and health promotion, why some longevity clinics are ahead of the evidence, and how intrinsic capacity could reshape healthcare funding and drug development.In this episode, you'll learn:- Why disease alone is an incomplete measure of aging- How intrinsic capacity measures cognitive, locomotive, psychological, sensory and vitality domains- Why better standardized measures could help shorten aging intervention trials- How early-life health can influence capacity decades later- Why healthcare systems could eventually reward improvements in health rather than throughputIf you want to understand how measuring function could change geroscience, clinical trials and healthcare itself, this episode connects aging biology with practical measures of how well people actually live.Subscribe for weekly episodes that explore longevity science, preventative medicine, and the systems shaping how we live longer and better.----------Host: Phil Newman: https://qrco.de/bgXpNY




